Intraperitoneal drug therapy: an advantage.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 20156151)

Published in Curr Clin Pharmacol on May 01, 2010

Authors

Kunal Chaudhary1, Shadi Haddadin, Ravi Nistala, Chris Papageorgio

Author Affiliations

1: Clinical Medicine, University of Missouri-Columbia School of Medicine, Division of Nephrology and Hypertension, Harry S Truman VA Medical Center, 800 Hospital Dr., Columbia, MO 65201, USA. chaudharyk@health.missouri.edu

Articles by these authors

Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol (2011) 1.73

Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem (2006) 1.62

Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension (2008) 1.23

Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats. Endocrinology (2013) 1.15

The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne) (2013) 1.06

Angiotensin II activation of mTOR results in tubulointerstitial fibrosis through loss of N-cadherin. Am J Nephrol (2011) 1.03

Insulin resistance, oxidative stress, and podocyte injury: role of rosuvastatin modulation of filtration barrier injury. Am J Nephrol (2007) 0.99

Photoacoustic detection of melanoma micrometastasis in sentinel lymph nodes. J Biomech Eng (2009) 0.95

The emerging role of biomarkers in diabetic and hypertensive chronic kidney disease. Curr Diab Rep (2010) 0.93

Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat. Am J Physiol Renal Physiol (2009) 0.89

Combination of direct renin inhibition with angiotensin type 1 receptor blockade improves aldosterone but does not improve kidney injury in the transgenic Ren2 rat. Regul Pept (2012) 0.87

DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes. Cardiorenal Med (2013) 0.86

Angiotensin receptor blockers for the reduction of proteinuria in diabetic patients with overt nephropathy: results from the AMADEO study. Vasc Health Risk Manag (2009) 0.85

Resistant hypertension in the high-risk metabolic patient. Curr Diab Rep (2011) 0.83

Gestational Diabetes and the Offspring: Implications in the Development of the Cardiorenal Metabolic Syndrome in Offspring. Cardiorenal Med (2012) 0.82

Anemia and chronic kidney disease: making sense of the recent trials. Rev Recent Clin Trials (2012) 0.82

Mineralocorticoid receptor-dependent proximal tubule injury is mediated by a redox-sensitive mTOR/S6K1 pathway. Am J Nephrol (2011) 0.81

Melanoma biomarkers: Vox clamantis in deserto (Review). Oncol Lett (2010) 0.81

Tissue-specific expression of GLP1R in mice: is the problem of antibody nonspecificity solved? Diabetes (2014) 0.81

Using genetic variation to optimize cancer chemotherapy. Clin Adv Hematol Oncol (2003) 0.80

Detection of melanoma cells in vitro using an optical detector of photoacoustic waves. Lasers Surg Med (2010) 0.80

A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer. Gastrointest Cancer Res (2012) 0.78

Over-nutrition contributes to tubulointerstitial fibrosis by targeting nutrient-sensing kinases: role for the mTOR/S6K pathway. Cell Cycle (2012) 0.77

Bioabsorbable coronary stents--are these the next big thing in coronary angioplasty? Recent Pat Cardiovasc Drug Discov (2010) 0.77

Update on the role of rituximab in kidney diseases and transplant. Expert Opin Biol Ther (2011) 0.76

Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins. J Clin Lipidol (2008) 0.75

Is there a role for the incretin system in blood pressure regulation? Curr Hypertens Rep (2014) 0.75

Bioinformatic prediction of ultraviolet light mutagenesis sensitivity of human genes and a method for genetically engineering UVB resistance. Cancer Inform (2011) 0.75

Gemcitabine and cisplatin-induced tumor lysis syndrome in a patient with gallbladder carcinoma: A case report. Oncol Lett (2013) 0.75

The importance of early identification of chronic kidney disease. Mo Med (2011) 0.75

Dual renin-angiotensin system blockade in the ONTARGET study: clinically relevant risk for the kidney? Curr Hypertens Rep (2009) 0.75

Is there a future for direct renin inhibitors? Expert Opin Investig Drugs (2010) 0.75

Stenting renal artery stenosis: what is the fuss all about? Rev Recent Clin Trials (2010) 0.75